The winter season brings out the best in pumpkin, aka kaddoo, because this low-calorie vegetable delivers essential nutrients ...

Praxis Precision Medicines, Inc. is upgraded to Strong Buy, driven by pipeline progress and positive Phase 3 data for ...

The global syndrome therapeutics market size was valued at US$ 147.4 Mn in 2024 and is projected to reach US$ 407.3 Mn by ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

PN-943 (IBD Program) -- Oral, gut-restricted alpha-4-beta-7 integrin antagonist demonstrated greater than threefold improved ...

Two NEJM trials report conflicting results on long-term beta-blockers after MI in patients with preserved ejection fraction, ...

The heart medication can ease physical symptoms of panic, making them popular for job interviews, public speaking events and ...

A collaborative effort among international research teams provides the most definitive statement yet on the usefulness of ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blockers did not improve clinical outcomes after ...

Beta-blockers provide no clinical benefit to post-MI patients with preserved left ventricular ejection fraction, according to a potentially paradigm-changing meta-analysis. The findings, published ...

For over four decades, many heart attack survivors have been sent home with a prescription for beta-blockers, which are drugs that impact the effects of hormones and adrenaline on the heart and blood ...